List view / Grid view
28 June 2016 | By Victoria White, Digital Content Producer
Combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumours...
21 June 2016 | By Victoria White, Digital Content Producer
NIH and Fiocruz have begun a study to evaluate the health risks that Zika virus infection poses to pregnant women and their developing foetuses...
5 April 2016 | By Victoria White
Research will include studies into how combinations of adjuvants interact with the immune system, and how synergies between adjuvants can be optimised...
26 February 2016 | By Victoria White
A single monoclonal antibody isolated from a human survivor of Ebola virus completely protected monkeys from lethal infection with the virus...
13 January 2016 | By Victoria White
NIAID has awarded $5 million in funding for 24 research projects to help address the growing health threat of antibiotic resistance...
21 October 2015 | By Victoria White
The investigational aerosol vaccine protected rhesus macacques from pulmonary TB infection better than the similarly delivered BCG vaccine...
26 August 2015 | By Victoria White
A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults...
24 August 2015 | By Victoria White
Ocata has been awarded a SBIR Phase 1 grant to fund further preclinical development of Ocata’s proprietary Hemangio-derived Mesenchymal Cell (HMC) product...
17 August 2015 | By Victoria White
Researchers have developed an experimental, nanoparticle-based vaccine against Epstein-Barr virus that can induce potent neutralising antibodies in animals...
